Generate Biomedicines (GENB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Generate Biomedicines reported total assets of $330.18M and total liabilities of $953.38M. Shareholders' equity was negative at −$615.97M, meaning liabilities exceed assets. Total debt stood at $68.53M against $221.50M in cash and short-term investments, a net cash position of $152.97M.

Generate Biomedicines Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Generate Biomedicines, Inc. (GENB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024
Period ending	Dec 2025	Dec 2024
Current Assets
Cash and Cash Equivalents	121.65	176.27
Short-Term Investments	99.85	217.36
Cash & Short-Term Investments	221.50	393.63
Accounts Receivable	0.00	0.31
Inventory	0.00	0.00
Other Current Assets	12.87	12.13
Total Current Assets	234.37	407.49
Non-Current Assets
Property, Plant & Equipment (Net)	89.01	101.07
Other Non-Current Assets	6.81	9.70
Total Non-Current Assets	95.82	110.77
Total Assets	330.18	518.26
Current Liabilities
Accounts Payable	3.84	5.67
Short-Term Debt	15.01	16.72
Accrued Liabilities	42.16	6.03
Deferred Revenue	21.19	42.43
Other Current Liabilities	42.16	2.43
Total Current Liabilities	82.20	86.63
Non-Current Liabilities
Long-Term Debt	53.52	60.26
Other Non-Current Liabilities	813.15	0.35
Total Non-Current Liabilities	871.18	866.72
Total Liabilities	953.38	953.35
Stockholders' Equity
Common Stock	0.05	0.03
Retained Earnings	-676.29	-473.14
Accumulated Other Comprehensive Income	0.11	0.12
Additional Paid-in Capital	60.17	38.47
Minority Interest	-7.23	-0.57
Shares Outstanding	127.45	127.45
Total Stockholders' Equity	-615.97	-434.52
Total Liabilities & Equity	330.18	518.26

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Generate Biomedicines Balance Sheet

How much debt does Generate Biomedicines have?

Generate Biomedicines had total debt of $68.53M as of Dec 31, 2025, against $221.50M in cash and short-term investments. Total debt was $76.97M a year earlier.

What are Generate Biomedicines's total assets?

Generate Biomedicines reported total assets of $330.18M as of Dec 31, 2025, down 36.3% from $518.26M a year earlier. Total liabilities were $953.38M.

What is Generate Biomedicines's shareholders' equity?

Generate Biomedicines's shareholders' equity was negative at −$615.97M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition